---
title: "Ribbon Acquisition Corp - Unit | 10-Q: FY2025 Q3 Revenue: USD 0"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/265962124.md"
datetime: "2025-11-14T16:27:06.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/265962124.md)
  - [en](https://longbridge.com/en/news/265962124.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/265962124.md)
generator: "portal-rs"
---

# Ribbon Acquisition Corp - Unit | 10-Q: FY2025 Q3 Revenue: USD 0

Revenue: As of FY2025 Q3, the actual value is USD 0.

EBIT: As of FY2025 Q3, the actual value is USD -989.57 K.

### Segment Revenue

-   Ribbon Acquisition Corporation has not generated any operating revenues as of September 30, 2025, as the company is a blank check company focused on effecting a business combination.

### Operational Metrics

-   For the three months ended September 30, 2025, the company reported a net income of $62,142, which consisted of operating expenses of $463,712 and income earned on marketable securities held in the Trust Account of $525,854.
-   For the nine months ended September 30, 2025, the company reported a net income of $569,295, which consisted of operating expenses of $892,007 and income earned on marketable securities held in the Trust Account of $1,461,302.

### Cash Flow

-   Net cash used in operating activities for the nine months ended September 30, 2025, was - $637,983.
-   Net cash used in investing activities was - $50,000,000, primarily due to the purchase of marketable securities held in the Trust Account.
-   Net cash provided by financing activities was $50,697,892, which included proceeds from the sale of public units through public offerings and private placements.

### Unique Metrics

-   The company completed its IPO on January 16, 2025, raising $50,000,000 through the sale of 5,000,000 units at $10.00 per unit.
-   Simultaneously, the company raised $2,200,000 through the sale of 220,000 private placement units at $10.00 per unit.

### Future Outlook and Strategy

#### Core Business Focus

-   Ribbon Acquisition Corporation aims to effectuate its initial business combination using cash from the IPO proceeds, private placement, and other potential financing methods.
-   The company has entered into a Business Combination Agreement with DRC Medicine Inc., which involves a series of transactions including a share exchange and merger, with the goal of DRC Medicine becoming a wholly-owned subsidiary of PubCo.

#### Non-Core Business

-   The company has not engaged in any operations or generated revenues to date, and its activities have been limited to organizational tasks and efforts to consummate the IPO and identify a target for a business combination.

#### Priority

-   The company has until January 16, 2026, to complete the initial business combination, failing which it will trigger an automatic winding up, dissolution, and liquidation.
-   Management has determined that these conditions raise substantial doubt about the company’s ability to continue as a going concern until the earlier of the consummation of the Business Combination or the date the company is required to liquidate.

### Related Stocks

- [RIBBU.US](https://longbridge.com/en/quote/RIBBU.US.md)

## Related News & Research

- [Gas supply cut from Indonesia accounts for less than 2% of Singaporeâs daily gas demand: EMA](https://longbridge.com/en/news/302973681.md)
- [Fast food chain Long John Silver's shutters another Singapore outlet after at least 5 closures this year](https://longbridge.com/en/news/302978153.md)
- [Small businesses struggling with inflation amid Trump tariffs ahead of midterms](https://longbridge.com/en/news/302972502.md)
- [Dongshan Precision retail IPO undersubscribed as Hong Kong mega listing flops](https://longbridge.com/en/news/302974270.md)
- [Crypto Strategist Who Nailed 2025 Bitcoin Top Warns BTC Could Drop Below $70,000 – Here’s His Price Target](https://longbridge.com/en/news/302980144.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**